Ka Shing Li

CIK 1686621 · last filed 2024-08-21

Ka Shing Li is a corporate insider who has filed 6 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for CDXC, was dated Aug 21, 2024. Across all open-market trades the lifetime net is −$147.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $631.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$631.11M

Companies

2

Total Filings

6

Lifetime Open-Market Net

-$147.08M

Filer Profile

Reported Address

7TH FLOOR, CHEUNG KONG CENTER
2 QUEEN'S ROAD CENTRAL
HONG KONG, K3 999077

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Niagen Bioscience, Inc. (CDXC) Delisted	10%+ Owner	0	$7.87	$0	$0	1	2024-08-21
CELH	10%+ Owner	19,965,408	$31.61	$631.11M	-$147.08M	5	2021-06-17

Recent Filings

6 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-08-21	Niagen Bioscience, Inc. (CDXC) Delisted	Sell (S)	−34,226,145	$0	EDGAR
2021-06-17	CELH	Sell (S)	−2,410,878	-$150.68M	EDGAR
2020-12-16	CELH	Other (J)	−166,666	$0	EDGAR
2019-09-16	CELH	Mixed	+1,355,901	$4.31M	EDGAR
2018-12-31	CELH	Buy (P)	—	$0	EDGAR
2017-01-04	CELH	Buy (P)	+800,000	$2.40M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.